Linden is a Chicago-based private investment firm focused exclusively on making leveraged investments in the health care and life science market. Linden was formed in 2002 as a continuation of a successful investment strategy developed by its principals in the 1990s at First Chicago Equity Capital (FCEC). The firm is comprised of private equity and operating executives working in tandem to oversee its governance program for growth and value creation. Linden seeks to develop new investment opportunities by leveraging its network of relationships throughout the health care and life science industry. The firm invests across a broad spectrum of traditional healthcare, health & wellness, public and environmental health and research-related companies. To invest in mature companies of all sizes, Linden formed an alliance with Madison Dearborn Partners to pursue large healthcare and life science buyout transactions (transactions requiring more than $50 million in private equity capital). Linden pursues smaller transactions (requiring less than $50 million in private equity capital) using its own funds.
